A panelist discusses how the new doravirine and islatravir combination offers an alternative to integrase inhibitor-based ...

Even after decades of research, there is no cure for the disease HIV causes, AIDS. But lenacapavir, born out of research on ...

A panelist discusses how a new drug combination of doravirine and islatravir was compared to a standard bictegravir-based ...

A cross-sectional analysis shows that long-acting antiretroviral therapy sustains viral suppression regardless of initial ...

On April 22, the CDC allegedly informed Emory University in Atlanta that its large HIV self-testing program was being ...

mainly because the persistence of viral reservoirs means that people living with HIV need to take lifelong antiretroviral ...

Researchers at UVA Health are urging for clinical trials to explore whether certain HIV medications, known as nucleoside ...

Long-acting injectable antiretroviral therapy (ART) can be administered at home to persons living with HIV as safely and ...

Research led by Professor Adrie Bekker is paving the way for an important HIV medicine to be made available to neonates in a ...

Patients in historically redlined neighborhoods experience significantly longer delays in achieving HIV viral suppression ...

However, cuts to HIV treatment and prevention threaten to roll back this progress and endanger the lives and human rights of millions of people around the world. The Independent reports that ...